RTSN$11.46-6.60%
Retension Pharmaceuticals, Inc.
Sector: Pharmaceutical PreparationsIndustry: Medical - PharmaceuticalsCountry: USExchange: Nasdaq
Mkt Cap & EV:$95.49M /
Float & O/S:3.72M / 8.33M
Est. Net Cash/Sh:
Inst Own:Not measured
DilutionScan read 22 of Retension Pharmaceuticals, Inc.'s SEC filings and found 3 warrant series, 2 convertibles, 1 S-1 registration and 1 completed offering on file for RTSN. The latest dilution event on file is an offering on Oct 13, 2026. Analysis updated Nov 13, 2026.